Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: Pharmacokinetics, pharmacodynamics, and clinical activity

Guido Marcucci, Wendy Stock, Guowei Dai, Rebecca B. Klisovic, Shujun Liu, Marko I. Klisovic, William Blum, Cheryl Kefauver, Dorie A. Sher, Margaret Green, Mollie Moran, Kati Maharry, Steven Novick, Clara D. Bloomfield, James A. Zwiebel, Richard A. Larson, Michael R. Grever, Kenneth K. Chan, John C. Byrd

Research output: Contribution to journalArticlepeer-review

122 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: Pharmacokinetics, pharmacodynamics, and clinical activity'. Together they form a unique fingerprint.

Medicine & Life Sciences